Nuvalent (NASDAQ:NUVL) Upgraded to Outperform by SVB Leerink

SVB Leerink upgraded shares of Nuvalent (NASDAQ:NUVL – Free Report) from a market perform rating to an outperform rating in a research note published on Monday, MarketBeat Ratings reports. SVB Leerink currently has $110.00 price target on the stock, up from their previous price target of $69.00. NUVL has been the subject of a number […]

Related Keywords

Leerink Partnrs ,Robertw Baird ,Matthew Shair ,Nuvalent Inc ,Metlife Investment Management ,Jpmorgan Chase Co ,York Mellon Corp ,Blackrock Inc ,Securities Exchange Commission ,Free Report ,Marketbeat Ratings ,Moderate Buy ,Get Free Report ,Director Matthew Shair ,Exchange Commission ,Darlene Noci ,New York Mellon Corp ,Life Investment Management ,Nuvalent Daily ,